A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
NCT ID: NCT06902077
Last Updated: 2025-12-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2025-11-25
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low-Carb/Time-restricted Feeding Protocol in Insulin-Using Type 2 Diabetics
NCT04558827
Transition of Adolescents and Young Adults With Diabetes From Pediatric to Adult Care
NCT01109797
An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer
NCT04742751
Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)
NCT04536480
Blood Glucose Response to Meals of Varying Glycemic Index in Youth With Type 1 & 2 Diabetes
NCT00545727
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
T2D in youth is different from T2D in adults. Teens with T2D have more insulin resistance and their bodies struggle to make enough insulin. Unfortunately, common diabetes medications do not stop the disease from getting worse. Better treatment options for young people with T2D are needed.
T2D happens when the body becomes resistant to insulin and the pancreas struggles to keep up. Diet is a key part of managing T2D, but there are no clear guidelines for the best diet for teens with diabetes.
In adults, low-carbohydrate diets (LCDs) have been shown to:
* Lower blood sugar and improve diabetes control
* Improve insulin function and protect the pancreas
* Reduce the need for diabetes medications
* Help with weight loss, especially in areas of harmful fat like the liver and belly
While LCDs have been well-studied in adults, there is very little research on how they affect adolescents with T2D. A few small studies suggest that reducing carbs may help teens with obesity and fatty liver disease, but we need more evidence to know for sure.
Study Objective This study will test whether a low-carbohydrate diet (LCD) can help improve blood sugar control and insulin function in adolescents with T2D. The investigators will compare it to the standard diet for diabetes care.
How the Study Works
The investigators will conduct a randomized controlled trial (RCT), meaning that participants will be randomly placed into one of two groups:
* Low-Carb Diet (LCD): 50-80 grams of carbohydrates per day
* Standard Diabetes Diet (SCD): A diet based on current guidelines
The study will last 24 weeks (6 months). Participants will keep food records and meet with a dietitian to track their progress.
What The Study Will Measure
The investigators will test whether the low-carb diet helps improve:
* Blood sugar control (measured by HbA1c)
* Insulin function and resistance (measured by an oral glucose tolerance test)
* Weight and fat loss, especially in harmful fat stores
* Triglycerides and cholesterol levels
* Need for diabetes medications
What The Study Expect to Find
The investigators believe that teens who follow a low-carb diet will have:
* Better blood sugar control
* Less insulin resistance
* More weight loss, especially from harmful fat
* Lower triglycerides and better cholesterol levels
* Less need for diabetes medications
This study will help us understand whether reducing carbs is a safe and effective way to improve diabetes in teens.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low carb diet
Participants in this group will limit the amount of carbohydrates they eat each day to 50-80 grams.
This means eating fewer sugars and starches (like bread, pasta, rice, and sweets). Instead, meals will focus on protein, healthy fats, and non-starchy vegetables. Participants will track their food and meet with a dietitian to help them stick to the plan.
low carb diet
diet based on low carb with max 50-80 grams of carbohydrates daily
Standard of care
Participants in this group will follow the current standard diet for managing diabetes. This includes balanced meals with carbohydrates, protein, and fats, based on regular diabetes guidelines.
Participants will track their food and meet with a dietitian to help them stay on track.
diabetic diet
Balanced diet based on standard of care recommendations for type 2 diabetes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
low carb diet
diet based on low carb with max 50-80 grams of carbohydrates daily
diabetic diet
Balanced diet based on standard of care recommendations for type 2 diabetes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diabetes diagnosis \>3 months to ensure stable baseline glycemic control
* HbA1C between 6.5- 8.5%
* BMI \>85th percentile
* Negative pancreatic autoantibodies
* Stable dose of anti-diabetic drugs GLP-1, metformin, SGLT-2 inhibitors, for 3 months
Exclusion Criteria
* Renal impairment measured as creatinine \> 1 mg/dL
* Hepatic dysfunction measured as AST and ALT \>100 IU/ml
12 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's of Alabama
OTHER
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ortal Resnick
Fellow- Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ortal Resnick, MD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham/ Children's of Alabama
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3130035.000.213130035.31165200
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
IRB-300014030
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.